AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
What is the latest Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹4.93 Cr |
| Mar2024 | ₹5.68 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹47 Cr |
| Mar2021 | ₹29 Cr |
How is Consolidated Net Profit of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.93 Cr | -13.20 | |
| Mar2024 | ₹5.68 Cr | -50.37 | |
| Mar2023 | ₹11 Cr | -75.76 | |
| Mar2022 | ₹47 Cr | 60.86 | |
| Mar2021 | ₹29 Cr | - | |
Compare Consolidated Net Profit of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹221.5 Cr | -0.2% | 4.2% | -46.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.2% |
4.2% |
-46.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses